Literature DB >> 24390320

Core binding factor beta plays a critical role by facilitating the assembly of the Vif-cullin 5 E3 ubiquitin ligase.

Jennifer L Fribourgh1, Henry C Nguyen, Leslie S Wolfe, David C Dewitt, Wenyan Zhang, Xiao-Fang Yu, Elizabeth Rhoades, Yong Xiong.   

Abstract

UNLABELLED: The HIV-1 virion infectivity factor (Vif) targets the cellular cytidine deaminases APOBEC3G (A3G) and APOBEC3F (A3F) for degradation via the host ubiquitin-proteasome pathway. Vif recruits a cellular E3 ubiquitin ligase to polyubiquitinate A3G/F. The activity of Vif critically depends on the cellular core binding factor beta (CBFβ). In this study, we investigated the Vif-CBFβ interaction and the role of CBFβ in the E3 ligase assembly. Vif-CBFβ interaction requires an extensive region of Vif spanning most of its amino terminus and zinc finger region, and cullin 5 (Cul5) binding enhances the stability of the Vif-CBFβ interaction. Our results further demonstrate that CBFβ plays a critical role in facilitating Cul5 binding to the Vif/elongin B/elongin C complex. Vif, with or without bound substrate, is unable to bind Cul5 in the absence of CBFβ. These studies support the notion that CBFβ serves as a molecular chaperone to facilitate Vif-E3 ligase assembly. IMPORTANCE: The host antiviral restriction factors A3G/F inhibit viral replication. The HIV-1 protein Vif targets A3G/F for degradation. This immune evasion activity of Vif is dependent on the cellular factor CBFβ. Multiple regions of Vif are known to be important for Vif function, but the mechanisms are unclear. The studies described here provide important information about the Vif-CBFβ interaction interface and the function of CBFβ in E3 ligase assembly. In particular, our comprehensive Vif-CBFβ interface mapping results help to delineate the role of various Vif regions, determining if they are important for binding CBFβ or A3G/F. Furthermore, our studies reveal an important potential mechanism of CBFβ that has not been shown before. Our results suggest that CBFβ may serve as a molecular chaperone to enable Vif to adopt an appropriate conformation for interaction with the Cul5-based E3 ligase. This study advances our understanding of how CBFβ facilitates the Vif-mediated degradation of APOBEC3 proteins.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390320      PMCID: PMC3957930          DOI: 10.1128/JVI.03824-13

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex.

Authors:  Xianghui Yu; Yunkai Yu; Bindong Liu; Kun Luo; Wei Kong; Panyong Mao; Xiao-Fang Yu
Journal:  Science       Date:  2003-10-16       Impact factor: 47.728

2.  Phosphorylation of a novel SOCS-box regulates assembly of the HIV-1 Vif-Cul5 complex that promotes APOBEC3G degradation.

Authors:  Andrew Mehle; Joao Goncalves; Mariana Santa-Marta; Mark McPike; Dana Gabuzda
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

3.  Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.

Authors:  Edmund N C Newman; Rebecca K Holmes; Heather M Craig; Kevin C Klein; Jaisri R Lingappa; Michael H Malim; Ann M Sheehy
Journal:  Curr Biol       Date:  2005-01-26       Impact factor: 10.834

4.  Primate lentiviral virion infectivity factors are substrate receptors that assemble with cullin 5-E3 ligase through a HCCH motif to suppress APOBEC3G.

Authors:  Kun Luo; Zuoxiang Xiao; Elana Ehrlich; Yunkai Yu; Bindong Liu; Shu Zheng; Xiao-Fang Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-02       Impact factor: 11.205

5.  Assembly of HIV-1 Vif-Cul5 E3 ubiquitin ligase through a novel zinc-binding domain-stabilized hydrophobic interface in Vif.

Authors:  Zuoxiang Xiao; Elana Ehrlich; Yunkai Yu; Kun Luo; Tao Wang; Chunjuan Tian; Xiao-Fang Yu
Journal:  Virology       Date:  2006-03-13       Impact factor: 3.616

6.  Differential requirement for conserved tryptophans in human immunodeficiency virus type 1 Vif for the selective suppression of APOBEC3G and APOBEC3F.

Authors:  Chunjuan Tian; Xianghui Yu; Wei Zhang; Tao Wang; Rongzhen Xu; Xiao-Fang Yu
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

7.  Mutational analysis of the human immunodeficiency virus type 1 Vif protein.

Authors:  J H Simon; A M Sheehy; E A Carpenter; R A Fouchier; M H Malim
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

8.  Selective assembly of HIV-1 Vif-Cul5-ElonginB-ElonginC E3 ubiquitin ligase complex through a novel SOCS box and upstream cysteines.

Authors:  Yunkai Yu; Zuoxiang Xiao; Elana S Ehrlich; Xianghui Yu; Xiao-Fang Yu
Journal:  Genes Dev       Date:  2004-12-01       Impact factor: 11.361

9.  HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.

Authors:  Mariana Marin; Kristine M Rose; Susan L Kozak; David Kabat
Journal:  Nat Med       Date:  2003-10-05       Impact factor: 53.440

Review 10.  Core-binding factors in hematopoiesis and immune function.

Authors:  Marella F T R de Bruijn; Nancy A Speck
Journal:  Oncogene       Date:  2004-05-24       Impact factor: 9.867

View more
  26 in total

Review 1.  HIV suppression by host restriction factors and viral immune evasion.

Authors:  Xiaofei Jia; Qi Zhao; Yong Xiong
Journal:  Curr Opin Struct Biol       Date:  2015-05-16       Impact factor: 6.809

Review 2.  The Road Less Traveled: HIV's Use of Alternative Routes through Cellular Pathways.

Authors:  Ailie Marx; Akram Alian
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

3.  Core-binding factor subunit beta is not required for non-primate lentiviral Vif-mediated APOBEC3 degradation.

Authors:  Youwei Ai; Dantong Zhu; Cuihui Wang; Chao Su; Jian Ma; Jianzhang Ma; Xiaojun Wang
Journal:  J Virol       Date:  2014-08-13       Impact factor: 5.103

Review 4.  Structural insights for HIV-1 therapeutic strategies targeting Vif.

Authors:  Jason D Salter; Guillermo A Morales; Harold C Smith
Journal:  Trends Biochem Sci       Date:  2014-08-12       Impact factor: 13.807

5.  Cellular requirements for bovine immunodeficiency virus Vif-mediated inactivation of bovine APOBEC3 proteins.

Authors:  Wenyan Zhang; Hong Wang; Zhaolong Li; Xin Liu; Guanchen Liu; Reuben S Harris; Xiao-Fang Yu
Journal:  J Virol       Date:  2014-08-20       Impact factor: 5.103

6.  A novel HIV-1 inhibitor that blocks viral replication and rescues APOBEC3s by interrupting vif/CBFβ interaction.

Authors:  Sizhu Duan; Shiqi Wang; Yanan Song; Nan Gao; Lina Meng; Yanxin Gai; Ying Zhang; Song Wang; Chu Wang; Bin Yu; Jiaxin Wu; Xianghui Yu
Journal:  J Biol Chem       Date:  2020-08-19       Impact factor: 5.157

Review 7.  Cullin-RING E3 Ubiquitin Ligases: Bridges to Destruction.

Authors:  Henry C Nguyen; Wei Wang; Yong Xiong
Journal:  Subcell Biochem       Date:  2017

Review 8.  Structural perspectives on HIV-1 Vif and APOBEC3 restriction factor interactions.

Authors:  Farshad C Azimi; Jeffrey E Lee
Journal:  Protein Sci       Date:  2019-11-29       Impact factor: 6.725

9.  Conserved Interaction of Lentiviral Vif Molecules with HIV-1 Gag and Differential Effects of Species-Specific Vif on Virus Production.

Authors:  Wenwen Zheng; Limian Ling; Zhaolong Li; Hong Wang; Yajuan Rui; Wenying Gao; Shaohua Wang; Xing Su; Wei Wei; Xiao-Fang Yu
Journal:  J Virol       Date:  2017-03-13       Impact factor: 5.103

10.  Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.

Authors:  Yusuke Matsui; Keisuke Shindo; Kayoko Nagata; Noriyoshi Yoshinaga; Kotaro Shirakawa; Masayuki Kobayashi; Akifumi Takaori-Kondo
Journal:  J Biol Chem       Date:  2016-10-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.